Calton & Associates’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$686K Sell
5,423
-82
-1% -$10.4K 0.12% 163
2025
Q1
$704K Sell
5,505
-111
-2% -$14.2K 0.16% 124
2024
Q4
$743K Buy
5,616
+3,034
+118% +$401K 0.33% 76
2024
Q3
$376K Sell
2,582
-3,255
-56% -$474K 0.14% 145
2024
Q2
$801K Sell
5,837
-429
-7% -$58.9K 0.4% 65
2024
Q1
$860K Sell
6,266
-398
-6% -$54.6K 0.42% 57
2023
Q4
$905K Buy
+6,664
New +$905K 0.36% 64
2023
Q3
Sell
-7,045
Closed -$894K 179
2023
Q2
$894K Sell
7,045
-83
-1% -$10.5K 0.42% 66
2023
Q1
$921K Sell
7,128
-316
-4% -$40.8K 0.43% 64
2022
Q4
$977K Buy
7,444
+3,694
+99% +$485K 0.38% 65
2022
Q3
$438K Buy
3,750
+2
+0.1% +$234 0.25% 99
2022
Q2
$440K Sell
3,748
-357
-9% -$41.9K 0.24% 106
2022
Q1
$534K Sell
4,105
-585
-12% -$76.1K 0.16% 154
2021
Q4
$715K Sell
4,690
-723
-13% -$110K 0.19% 135
2021
Q3
$875K Buy
5,413
+1,219
+29% +$197K 0.19% 131
2021
Q2
$687K Buy
4,194
+287
+7% +$47K 0.13% 163
2021
Q1
$588K Sell
3,907
-72
-2% -$10.8K 0.11% 169
2020
Q4
$603K Sell
3,979
-839
-17% -$127K 0.11% 156
2020
Q3
$652K Sell
4,818
-680
-12% -$92K 0.13% 129
2020
Q2
$752K Sell
5,498
-4,722
-46% -$646K 0.16% 105
2020
Q1
$1.1M Sell
10,220
-737
-7% -$79.4K 0.27% 69
2019
Q4
$1.32M Sell
10,957
-394
-3% -$47.5K 0.27% 72
2019
Q3
$1.13M Buy
11,351
+342
+3% +$34K 0.25% 74
2019
Q2
$1.2M Sell
11,009
-290
-3% -$31.6K 0.34% 53
2019
Q1
$1.26M Sell
11,299
-805
-7% -$90K 0.38% 50
2018
Q4
$1.17M Buy
12,104
+133
+1% +$12.8K 0.43% 49
2018
Q3
$1.46M Sell
11,971
-28
-0.2% -$3.42K 0.43% 38
2018
Q2
$1.41M Buy
11,999
+1,796
+18% +$211K 0.41% 41
2018
Q1
$1.09M Buy
10,203
+59
+0.6% +$6.3K 0.32% 66
2017
Q4
$1.18M Buy
+10,144
New +$1.18M 0.3% 57